A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans.

MLA

Pleguezuelos, Olga, et al. “A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans.” Clinical and Vaccine Immunology : CVI, vol. 22, no. 7, July 2015, pp. 828–35. EBSCOhost, https://doi.org/10.1128/CVI.00098-15.

APA

Pleguezuelos, O., Robinson, S., Fernández, A., Stoloff, G. A., Mann, A., Gilbert, A., Balaratnam, G., Wilkinson, T., Lambkin-Williams, R., Oxford, J., & Caparrós-Wanderley, W. (2015). A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans. Clinical and Vaccine Immunology : CVI, 22(7), 828–835. https://doi.org/10.1128/CVI.00098-15

Chicago

Pleguezuelos, Olga, Stuart Robinson, Ana Fernández, Gregory A Stoloff, Alex Mann, Anthony Gilbert, Ganesh Balaratnam, et al. 2015. “A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans.” Clinical and Vaccine Immunology : CVI 22 (7): 828–35. doi:10.1128/CVI.00098-15.